"49702-231-13" National Drug Code (NDC)

Triumeq 30 TABLET, FILM COATED in 1 BOTTLE (49702-231-13)
(ViiV Healthcare Company)

NDC Code49702-231-13
Package Description30 TABLET, FILM COATED in 1 BOTTLE (49702-231-13)
Product NDC49702-231
Product Type NameHUMAN PRESCRIPTION DRUG
Proprietary NameTriumeq
Non-Proprietary NameAbacavir Sulfate, Dolutegravir Sodium, Lamivudine
Dosage FormTABLET, FILM COATED
UsageORAL
Start Marketing Date20140822
Marketing Category NameNDA
Application NumberNDA205551
ManufacturerViiV Healthcare Company
Substance NameABACAVIR SULFATE; DOLUTEGRAVIR SODIUM; LAMIVUDINE
Strength600; 50; 300
Strength Unitmg/1; mg/1; mg/1
Pharmacy ClassesCytochrome P450 1A1 Inhibitors [MoA], HIV Integrase Inhibitors [MoA], Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]

Find more : http://www.hipaaspace.com/medical_billing/coding/national.drug.codes/49702-231-13